AgeTech Innovations, Colorectal Cancer in Youth, and AI Chatbots in Healthcare
E414 • Apr 21, 2026 • 19 minsIn this episode, Dr. Chi-Ming Chow introduces AgeTech innovations and their presence at the HLTH conference, highlighting key partnerships. He addresses the concerning rise of colorectal cancer in younger adults, discussing risk factors and the importance of early detection. The episode explores the health benefits of yogurt and provides tips on selecting the best options. Dr. Chow examines the role of AI chatbots in healthcare, focusing on concerns and the need for education. He delves into the potential link between ear conditions and dementia risk. Additionally, the episode emphasizes the importance of public health education in K-12 schools. Dr. Chow concludes with a comprehensive wrap-up of these topics.
Respiratory Illnesses, Vaccination Trends, and Advances in Gastroenterology
E413 • Apr 17, 2026 • 17 minsIn this episode, Dr. Chi-Ming Chow addresses the increasing respiratory illnesses in Canada and the concerning decline in vaccination rates. He provides updates in the fields of gastroenterology and hepatology, focusing on colorectal cancer screening and hepatocellular carcinoma surveillance. Dr. Chow examines liver transplant outcomes and recent advances in IBD treatment. The episode also highlights the approval of Neffy for allergic reactions and the impact of "office air" on appearance and well-being. Additionally, Dr. Chow explores the role of conversational AI in mental health support. He concludes with a wrap-up of these key health topics.
Ultrafine Particles, AI in Health Advice, and Refugee Healthcare Cuts
E412 • Apr 16, 2026 • 18 minsIn this episode, Dr. Chi-Ming Chow delves into the health and environmental implications of ultrafine particles, shedding light on their pervasive impact. He then explores the rising trend of AI tools for health advice, discussing their accessibility and the accompanying privacy concerns. Dr. Chow examines the surprising health benefits of sleeping without a pillow and addresses the proposed cuts to refugee health care in Canada. The episode also highlights common foot problems and their causes, providing practical insights. Finally, he discusses the positive effects of vigorous exercise on managing chronic diseases, offering listeners valuable health perspectives.
Tylenol and Autism, Refugee Healthcare Policy, and Weight Gain Risks
E411 • Apr 15, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow explores recent studies on Tylenol's potential link to autism and the FDA's stance on its use during pregnancy. He introduces Canada's new co-payment system for refugee healthcare and addresses criticism from advocacy groups and medical professionals. Dr. Chow also examines research on weight gain in one's twenties and its link to early mortality, emphasizing non-scale victories in weight loss. Featuring Saumya Sao's work with Stanford Medicine Outreach Program, the episode highlights challenges in healthcare information management. Dr. Chow concludes with a call for innovation in patient information systems.
Resident Doctors' Strike, AI in Healthcare, and Exercise Benefits
E410 • Apr 14, 2026 • 17 minsIn this episode, Dr. Chi-Ming Chow begins with an overview of the resident doctors' strike in England, examining the ongoing government negotiations and public opinion surrounding the issue. He then highlights the health benefits of exercise, particularly high-intensity interval training (HIIT). The episode also covers a new AI initiative by Google.org and the Johnson & Johnson Foundation, outlining its pillars and goals. Dr. Chow discusses the unexpected benefits and impacts of doctors' strikes, including training, workforce, and financial implications. He concludes with insights on graduation and encouragement for nurse practitioners, wrapping up with a thoughtful conclusion.
AI in Mental Health, Consciousness Studies, and Equitable Healthcare Access
E409 • Apr 13, 2026 • 14 minsIn this episode, Dr. Chi-Ming Chow explores the concept of digital folie à deux and the role of AI in psychiatric and mental health settings. He discusses how simulated empathy can alter patient narratives and the importance of addressing AI interactions in healthcare conversations. The episode also examines the design of AI for mental health, highlighting ethical considerations. Dr. Chow shifts focus to consciousness in vegetative state patients, followed by a discussion on air pollution, its health concerns, ongoing research, and mitigation strategies. He also covers colon cancer screening efforts for the homeless in Nova Scotia, emphasizing the need for equitable healthcare access. The episode wraps up with a summary and closing remarks.
Peptide Drug Risks, Plant-Based Diet Insights, and Vaccine Efficacy Studies
E408 • Apr 10, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow discusses Health Canada's warning on unauthorized peptide drugs and regulatory actions taken. He analyzes workforce cuts at Ottawa Hospital and their impact on patient care, offering service level recommendations. The episode also covers a study on plant-based diets and dementia risk from the Multiethnic Cohort Study. Dr. Chow explores the "Jessica" social media trend for calming toddlers, sharing expert opinions. Additionally, he reviews a study on calcium supplements, cardiovascular risk, and vitamin D, noting limitations. The episode concludes with insights on high-dose flu vaccines and Alzheimer's risk, emphasizing gender differences and study limitations.
Salt Risks, Bipolar II Insights, and AI in Medical Billing
E407 • Apr 9, 2026 • 9 minsIn this episode, Dr. Chi-Ming Chow provides an overview of salt usage, discussing health risks, gender differences, and lifestyle factors. He shares strategies to reduce salt intake with insights from dietitians and examines the broader health implications of salt consumption. The episode also delves into Bipolar II disorder, exploring health risks, comparisons with other mental health conditions, and the importance of care integration, alongside biological aspects and current research. Dr. Chow discusses the role of AI and chatbots in managing medical bills, highlighting cautions and privacy concerns. The episode concludes with a thoughtful sign-off.
Rare Diseases, HIV PrEP Access, and Innovations in Pediatric Cardiac Surgery
E406 • Apr 8, 2026 • 12 minsIn this episode, Dr. Chi-Ming Chow discusses Celine Dion's battle with stiff-person syndrome, highlighting the importance of raising awareness for rare diseases. He then examines gaps and disparities in HIV PrEP usage among youth, emphasizing the need to improve access for at-risk populations. The episode also covers the recent doctors' strike in England, exploring its causes and potential implications for the healthcare system. Dr. Chow delves into the innovative use of 3D printing in pediatric cardiac surgery, showcasing its transformative potential. The episode concludes with thoughts on the future of medical technology and its impact on patient care.
Thyroid Health, Sedentary Risks, and Mental Health Misinformation
E405 • Apr 7, 2026 • 16 minsIn this episode, Dr. Chi-Ming Chow begins with an overview of thyroid health and the factors leading to levothyroxine discontinuation in older adults, examining study findings and implications for thyroid hormone therapy. He then explores the application of bonsai principles to healthcare system reform. The episode highlights the impact of sedentary behavior on brain health and discusses strategies for reducing dementia risk through mental engagement and physical activity. Dr. Chow also addresses the prevalence of misleading mental health information on social media platforms. The episode wraps up with insights into these pressing health concerns.
Microplastics, Stroke Risk, Peptides, and Weight Loss Strategies
E404 • Apr 6, 2026 • 13 minsIn this episode, Dr. Chi-Ming Chow explores the health risks of microplastics, corporate responsibility, and public education. He also discusses predicting stroke risk after a transient ischemic attack, highlighting risk factors and the brain-heart connection. The rise of injectable peptides is examined, including trends, skepticism, and regulatory challenges, as well as the influence of social media. Expert health advice and insights on routinized eating for weight loss are provided. The episode wraps up with study limitations and final thoughts.
Quebec Funding, Drug Trends, and New Weight-Loss Pill Foundayo
E403 • Apr 3, 2026 • 13 minsIn this episode, Dr. Chi-Ming Chow begins by discussing Quebec's funding for English-speaking patients and its potential impact on healthcare access. He then highlights alarming trends in drug use in the United States, focusing on medetomidine and fentanyl, their risks, clinical effects, and challenges in managing these substances. Dr. Chow explores fluvoxamine as a potential treatment for long COVID, examining ongoing research and findings. The episode introduces the new weight-loss pill Foundayo, sharing clinical trial results, applications, benefits, side effects, and safety considerations. The episode concludes with closing remarks and a preview of tomorrow's topics.
Vaccine Program Changes, Nurse Cuts, and RNA Therapy for Heart Recovery
E402 • Apr 1, 2026 • 15 minsIn this episode, Dr. Chi-Ming Chow discusses recent changes to the Vaccine Injury Compensation Program and its impact on public confidence. He investigates the program's administration and the resulting concerns. The episode addresses nurse position cuts at London Health Sciences Centre, exploring staffing challenges, related lawsuits, and hospital responses. Dr. Chow highlights lobbying efforts for safe staffing ratios and advances in injectable RNA therapy for heart attack recovery. He examines the strain on mothers in pediatric care, its impact on mental health, and potential policy changes. Medicaid reform and telehealth are discussed as solutions to pediatric care failures. The episode concludes with Dr. Chow's sign-off.
Superbug Sniffing Dog, Sleep & Heart Health, and AI Governance in Healthcare
E401 • Mar 30, 2026 • 25 minsIn this episode, Dr. Chi-Ming Chow starts with the retirement of Angus, the superbug-sniffing dog, and his impact on healthcare. He explores a study on sleep and cardiovascular health, providing key research insights. A 30-day walking and strength program with nutrition tips is also introduced. Dr. Chow discusses scaling and deploying autonomous AI in healthcare, focusing on governance, risk controls, and regulatory validation. He highlights AI chatbots in mental health support, sharing Shannon Flaman's experience with Canadian healthcare access disparities. The episode concludes with a call for systemic changes.
Chronic Pain Breakthrough, Ontario Drug Site Closure, and New COVID Variant BA.3.2
E400 • Mar 26, 2026 • 16 minsIn this episode, Dr. Chi-Ming Chow delves into a range of topics. He explores a breakthrough in chronic back pain treatment and new research on parathyroid hormone. The episode also examines Ontario's decision to close supervised drug consumption sites and its public health implications. Dr. Chow updates listeners on the new COVID-19 variant BA.3.2 in the US and its potential impact. Additionally, he discusses the effects of the US oil embargo on the Cuban healthcare system and concludes with insights on the landmark trial against Meta and YouTube regarding social media addiction.
Virtual Healthcare in NB, Dementia Risks, and Drug Promotion Ethics
E399 • Mar 25, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow introduces the transition to virtual healthcare in New Brunswick and Quebec's proposed mental health legislation, providing insights into regional healthcare developments. He examines a Finnish study linking infections to an increased risk of dementia, highlighting significant findings. The episode includes a segment sponsored by PharmaCare. Dr. Chow discusses Manitoba's budget, noting an increase in healthcare spending alongside changes in affordability measures and tax credits. Additionally, he explores the role of social media influencers in the promotion of prescription drugs. The episode concludes with Dr. Chow's closing remarks.
US Heatwave, Pesticides & Parkinson's, and AI in Patient Care
E398 • Mar 24, 2026 • 17 minsIn this episode, Dr. Chi-Ming Chow introduces the topics with an overview of the current heatwave in the US, examining its historical context, the role of climate change, and resulting health impacts. He discusses recent study findings on pesticide exposure and its connection to Parkinson's disease, along with the current regulatory status. The episode also explores how AI is reshaping patient visits and the challenges faced within healthcare systems. Dr. Chow shares insights from travel nurse Megan Diaz on the functioning of hospital systems. Additionally, he discusses new research linking muscular strength to longevity in older women, providing valuable health insights.
Virtual Health Care, Blood Transfusion Policies, and Men's Mental Health Initiatives
E397 • Mar 23, 2026 • 20 minsIn this episode, Dr. Chi-Ming Chow introduces a range of topics starting with the effectiveness, payment models, and cultural shifts surrounding virtual health care in Canada. He discusses the updated policy by Jehovah's Witnesses regarding blood transfusions, offering insights into its implications. The episode examines sleep quality, highlighting contributing factors and gender differences. Dr. Chow also covers the relocation of nurse practitioners from the US to Canada, exploring the reasons behind this trend. Additionally, he discusses seasonal allergies management in the context of climate change and highlights men's mental health initiatives, like Cowboys Mud Racing. The episode concludes with a wrap-up.
Type 1 Diabetes & Dementia, Beauty Parlor Stroke, and AI in Breast Cancer Screening
E396 • Mar 20, 2026 • 19 minsIn this episode, Dr. Chi-Ming Chow welcomes listeners and delves into recent research on dementia risks in older adults with type 1 diabetes, highlighting key study findings. He explains the phenomenon of beauty parlor stroke syndrome and offers insights into its management. The episode also explores advancements in AI for breast cancer screening, discussing accompanying ethical considerations. Dr. Chow examines Ontario's electronic medical record system and its implications for primary care funding. He concludes by discussing the FDA's approval of Wegovy HD for obesity treatment, before offering his closing remarks and signing off.
MIND Diet & Brain Aging, Healthcare Workforce, and Adult ADHD Trends
E395 • Mar 18, 2026 • 22 minsIn this episode, Dr. Chi-Ming Chow introduces the latest insights on the MIND diet and its impact on brain aging, highlighting recent research findings. He examines the dynamics of the healthcare workforce in North America, discussing current challenges and opportunities. Dr. Chow also explores trends in Canadian health and disability, providing a comprehensive overview of the issues at hand. The episode delves into adult ADHD, focusing on current prescription patterns and their implications. Additionally, Dr. Chow mentions the sponsorship by Microsoft and HealthEx's Copilot Health, before wrapping up with an episode summary.


